SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

ImmunityBio at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

ImmunityBio brings 1 presentation to SITC 2026 in Phoenix, and exhibits at Booth 733. Its program centres on a new drug for HPV-associated head and neck tumors. It describes an early study testing the safety of IBRX-042 and finding the highest dose patients can tolerate.

OrganizationSITC 2026 Attendance
ImmunityBio
San Diego, CA
Biotech
Immunotherapy company developing IL-15 superagonist, NK cell and vaccine therapies; its Anktiva is approved for bladder cancer.
Booth
Exhibiting at Booth 733
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at ImmunityBio

Tell us what you sell and we’ll find the people at ImmunityBio most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction